source
- Lundbeck advances PACAP-targeting migraine drug after mid-stage trial shows reduction in migraine daysLundbeck reported new data from a mid-stage study of its experimental migraine prevention therapy, bocunebart, which targets the PACAP protein involved in headache pathways. The trial enrolled hun…
- Roche's daily incretin injection shows promise in Phase 2 trial for type 1 diabetesRoche reported that its experimental daily incretin injection achieved positive results in a Phase 2 study involving patients with type 1 diabetes. The study, the first mid-stage trial of a GLP-1…